Procter & Gamble (PG) Gains After Moving Up Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Procter & Gamble (PG) PT Lowered to $75 at JPMorgan
April 20, 2018 8:23 AM EDTJPMorgan lowered its price target on Procter & Gamble (NYSE: PG) to $75.00 (from $80.00) while maintaining a Neutral rating following the company's 3Q earnings report. PGs reported organic sales growth of +1% was a 100bps sequential deceleration on reported figures from 2Q. Management now expects... More
Procter & Gamble (PG) Acquires Merck KGaA's Consumer Health Unit for Approx. $4.2B
April 19, 2018 6:01 AM EDTThe Procter & Gamble Company (NYSE: PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.
This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery... More



